Filter By Industry
Filter By Tag

Newsroom

Oxipit.ai Press releases

1 - 10 of 20 Press Releases

Nov 21, 2022
AI medical imaging company Oxipit expanded its Quality product suite with quality assurance support for musculoskeletal X-rays, mammography images and lung CT scans.

Sep 28, 2022
With ChestLink, which can automatically identify normal chest X-rays, healthy patients can be instantly sent home after the examination, without the need to wait for the study report at the polyclinic.

Jul 18, 2022
Oxipit has conducted a retrospective validation study on ChestEye Quality performance. The study concludes that 1 in 552 (0.18%) chest X-ray studies reported by a radiologist include clinically significant diagnostic mistakes.

Jul 18, 2022
The new partnership aims to mitigate the risk associated with missed findings in CT medical imaging studies.

May 31, 2022
Following the CE certification of the first autonomous AI medical imaging application ChestLink, researchers in Finland released a preprint of a study on the application performance on real-world clinical data.

Apr 26, 2022
The companies conducted a joint pilot study, where Oxipit's ChestEye Quality AI software is employed for improved pulmonary nodule detection. The software was deployed in two major primary care centers in Lithuania.

Mar 29, 2022
Oxipit was granted CE Class IIb certification for ChestLink autonomous AI imaging suite. The application autonomously reports on chest X-rays featuring no abnormalities without any involvement from a radiologist.

Nov 24, 2021
At the annual RSNA meeting, the AI medical imaging company will present the new ChestEye Quality AI double reading tool.

Oct 05, 2021
AI medical imaging company Oxipit appointed Dany Chammas as their new Chief Commercial Officer.

Mar 02, 2021
The AI medical imaging company will showcase the first autonomous AI diagnostics application for healthy patient report automation.


Page: 1 2 Next
Oxipit.ai RSS Feed